GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
RGS1 |
RGS1, 1R20, BL34, IER1: Regulator of G-protein signaling 1 |
0.285 |
Evidence |
|
CCL24 |
CCL24, MPIF2, SCYA24: Small-inducible cytokine A24 precursor |
TACR1 |
TACR1, NK1R, TAC1R: Substance-P receptor |
0.285 |
Evidence |
|
CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
MC2R |
MC2R, ACTHR: Adrenocorticotropic hormone receptor |
0.285 |
Evidence |
|
CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
HCRTR2 |
HCRTR2: Orexin receptor type 2 |
0.285 |
Evidence |
|
PTGER1 |
PTGER1: Prostaglandin E2 receptor EP1 subtype |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.285 |
Evidence |
|
GPR37L1 |
GPR37L1, ETBRLP2: Endothelin B receptor-like protein 2 precursor |
CX3CL1 |
CX3CL1, A-152E5.2, FKN, NTT, SCYD1: Fractalkine precursor |
0.285 |
Evidence |
|
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
SHB |
SHB: SH2 domain-containing adapter protein B |
0.285 |
Evidence |
|
CXCL10 |
CXCL10, INP10, SCYB10: Small-inducible cytokine B10 precursor |
HRH4 |
HRH4, GPCR105: Histamine H4 receptor |
0.285 |
Evidence |
|
DRD5 |
DRD5, DRD1B, DRD1L2: D(1B) dopamine receptor |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.285 |
Evidence |
|
ADORA2B |
ADORA2B: Adenosine receptor A2b |
CCL17 |
CCL17, SCYA17, TARC: Small-inducible cytokine A17 precursor |
0.285 |
Evidence |
|
MLNR |
MLNR, GPR38, MTLR, MTLR1: Motilin receptor |
CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
0.285 |
Evidence |
|
CDH13 |
CDH13, CDHH: Cadherin-13 precursor |
KIFAP3 |
KIFAP3, SMAP: Kinesin-associated protein 3 |
0.285 |
Evidence |
|
CXCL10 |
CXCL10, INP10, SCYB10: Small-inducible cytokine B10 precursor |
SSTR4 |
SSTR4: Somatostatin receptor type 4 |
0.285 |
Evidence |
|
CCL27 |
CCL27, ILC, SCYA27: Small-inducible cytokine A27 precursor |
HRH2 |
HRH2 protein |
0.285 |
Evidence |
|
ADRA2B |
ADRA2B, ADRA2L1, ADRA2RL1: Alpha-2B adrenergic receptor |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.285 |
Evidence |
|
CXCL11 |
CXCL11, ITAC, SCYB11, SCYB9B: Small-inducible cytokine B11 precursor |
CCR8 |
CCR8, CKRL1, CMKBR8, CMKBRL2: C-C chemokine receptor type 8 |
0.285 |
Evidence |
|
CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
HRH4 |
HRH4, GPCR105: Histamine H4 receptor |
0.285 |
Evidence |
|
GPR12 |
GPR12: Probable G-protein coupled receptor 12 |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.285 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
RYK |
RYK, JTK5A: Tyrosine-protein kinase RYK precursor |
0.285 |
Evidence |
|
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
HRH4 |
HRH4, GPCR105: Histamine H4 receptor |
0.285 |
Evidence |
|
CCL3 |
CCL3, G0S19-1, MIP1A, SCYA3: Small-inducible cytokine A3 precursor |
OPN3 |
OPN3, ECPN: Opsin-3 |
0.285 |
Evidence |
|
CCBP2 |
CCBP2, CCR10, CMKBR9: Chemokine-binding protein 2 |
CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
0.285 |
Evidence |
|
CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
RXFP3 |
RXFP3, RLN3R1, SALPR: Relaxin-3 receptor 1 |
0.285 |
Evidence |
|
CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
BRS3 |
BRS3: Bombesin receptor subtype-3 |
0.285 |
Evidence |
|
CTRL |
PSMB10, MECL1: Proteasome subunit beta type-10 precursor |
PLK3 |
PLK3, CNK, FNK, PRK: Serine/threonine-protein kinase PLK3 |
0.285 |
Evidence |
|